Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.

Philipp BackhausBenjamin NotoNemanja AvramovicLena Sophie GrubertSebastian HussMartin BögemannLars SteggerMatthias WeckesserMichael SchäfersKambiz Rahbar

Published in: European journal of nuclear medicine and molecular imaging (2018)

The non-exclusivity of PSMA in prostate cancer opens a window to utilize the spectrum of available radioactive PSMA ligands for imaging and molecular characterization and maybe even therapy of non-prostate disease.

Keyphrases

prostate cancer
pet ct
pet imaging
radical prostatectomy
current status
benign prostatic hyperplasia
high resolution
stem cells
positron emission tomography
drug delivery
computed tomography
bone marrow
photodynamic therapy
mesenchymal stem cells